Skip to content

Addiction: all studies

Page 422 of 857: studies 4,211 to 4,220 of 8,563, newest first. Back to the addiction overview

Research

Mindfulness-based intervention and sexuality: a systematic review.

Trends in Psychiatry and Psychotherapy February 20, 2023 Amaia Miren Ciaurriz Larraz, Alejandro Villena Moya, Carlos Chiclana Actis

Objectives: Mindfulness has generated considerable interest in the last 2 decades in clinical and research settings. The efficacy of mindfulness has been evaluated for the sexual dysfunctions recognized by the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) and other sexual problems, such as compulsive sexual behavior disorder (CSBD), also known as sex addiction or...

Delta-8-THC association with psychosis: A case report with literature review

Frontiers in Psychiatry February 20, 2023 Chelsea R. Miller, Bradley G. Burk, Rachel E. Fargason et al. 16 citations

Background Cannabis (Δ 9 -THC) is the most commonly consumed illicit drug. The Agricultural Improvement Act of 2018 removed hemp, a strain of Cannabis sativa , as a controlled substance. This law allowed the plant to be processed into its components, which contain <0.3% Δ 9 -THC. As a result, delta-8-tetrahydrocannabinol (Δ 8 -THC), a federally unregulated substance, grew in popularity in 2020....

DOI: 10.3389/fpsyt.2023.1103123 (opens in new tab) Cannabis Psychosis Delta-9-tetrahydrocannabinol Antipsychotic +2

Effectiveness of four deconstructive meditative practices on well-being and self-deconstruction: study protocol for an exploratory randomized controlled trial.

Trials February 20, 2023 Javier García-campayo, Rinchen Hijar-Aguinaga, Yolanda López-del-hoyo et al. 6 citations

Introduction: The efficacy of interventions based on mindfulness and compassion has been demonstrated in both clinical and general population, and in different social contexts. These interventions include so-called attentional and constructive meditation practices, respectively. However, there is a third group, known as deconstructive meditation practices, which has not been scientifically...

Pharmacological effects of methylone and MDMA in humans

Frontiers in Pharmacology February 17, 2023 Lourdes Poyatos, Clara Pérez‐mañá, Olga Hladun et al. 26 citations

Methylone is one of the most common synthetic cathinones popularized as a substitute for 3,4-methylenedioxymethamphetamine (MDMA, midomafetamine) owing to its similar effects among users. Both psychostimulants exhibit similar chemistry (i.e., methylone is a β-keto analog of MDMA) and mechanisms of action. Currently, the pharmacology of methylone remains scarcely explored in humans. Herein, we...

The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology

International Journal of Molecular Sciences February 15, 2023 Martina di Bartolomeo, Tibor Stark, Serena di Martino et al. 23 citations

Adolescent exposure to cannabinoids as a postnatal environmental insult may increase the risk of psychosis in subjects exposed to perinatal insult, as suggested by the two-hit hypothesis of schizophrenia. Here, we hypothesized that peripubertal Δ9-tetrahydrocannabinol (aTHC) may affect the impact of prenatal methylazoxymethanol acetate (MAM) or perinatal THC (pTHC) exposure in adult rats. We...

DOI: 10.3390/ijms24043907 (opens in new tab) Dopaminergic Schizophrenia object-oriented programming Prefrontal cortex Cannabinoid +6

Experiences of psilocybin treatment for clinical conditions: A qualitative meta‐synthesis

International Journal of Mental Health Nursing February 13, 2023 Marie Crowe, Jenni Manuel, Dave Carlyle et al. 18 citations

Abstract There is increasing clinical interest in the use of psilocybin. There is emerging evidence of the efficacy of psilocybin for the treatment of a range of clinical conditions. Mental health nurses have a unique set of skills for caring for people who are hallucinating. To expand these skills to meet the developing clinical interest in the therapeutic use of psilocybin, it is helpful to...

DOI: 10.1111/inm.13127 (opens in new tab) Psilocybin Hallucinogen Psychotherapist Clinical psychology +1

The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy

Journal of Scientific Exploration February 11, 2023 Jeffery Heilman 2 citations

The potential benefits and deficits of the chemical compound psilocybin, particularly when paired with psychotherapeutic interventions, have been increasingly apparent top­ics of interest in social, academic, and scientific circles. The unusual nature of psilocybin poses many questions in Western culture. Three of them, which will be discussed in the following review, are (1) What is...

DOI: 10.31275/20222633 (opens in new tab) Psilocybin Psychotherapist Psychological intervention Hallucinogen +4

Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample

Scientific Reports February 11, 2023 Grant Jones, Joshua Lipson, Erica Wang 2 citations

Abstract Impairment in social functioning is a common source of morbidity across many mental health disorders, yet there is a dearth of effective and easily implemented interventions to support social functioning. MDMA/ecstasy and classic psychedelics (psilocybin, LSD, peyote, mescaline) represent two potential treatments for impairments in social functioning, as evidence suggests these...

N,N‐dimethyltryptamine affects electroencephalography response in a concentration‐dependent manner—A pharmacokinetic/pharmacodynamic analysis

CPT: Pharmacometrics & Systems Pharmacology February 10, 2023 Emma Eckernäs, Christopher Timmermann, Robin Carhart-Harris et al. 15 citations

Abstract N,N‐dimethyltryptamine (DMT) is a psychedelic substance and is being used as a research tool in investigations of the neurobiology behind the human consciousness using different brain imaging techniques. The effects of psychedelics have commonly been studied using electroencephalography (EEG) and have been shown to produce suppression of alpha power and increase in signal diversity....

DOI: 10.1002/psp4.12933 (opens in new tab) DMT Psychedelics Brain waves Consciousness research

Cannabis use and first onset Schizophrenia-like psychosis after traumatic brain injury in a patient with intracranial bullet

Journal of Substance Use February 7, 2023 M. Ergelen, M. Yalçın, Fikret Ferzan Gıynaş et al.

ABSTRACT Traumatic brain injury (TBI) is an important cause of mortality and morbidity worldwide. Cannabis use disorder and psychosis are rare but serious comorbidities seen after TBI. Recent studies indicate that the use of cannabis for self-medication may increase after TBI. Schizophrenia-like psychosis (SLP) is also seen, generally showing a late and gradual onset after TBI. Especially in...